Evonik Industries AG on Thursday said it has acquired Madrid-based biotechnology company innovativeHealth Group.
innoHealth’s technology platforms screen and combine natural ingredients and extracts to generate new dermo-cosmetic products.
The German chemicals company said the acquisition – expected to complete by the end of March – will allow it to expand its product development for active ingredients as part of its strategy to grow its innovation footprint within and beyond the personal care field.
“With this latest acquisition we have strengthened our innovative power in the area of cosmetic active ingredients. We will now be able to optimize the costs and development time, as well as achieve high quality and high performance products that show attractive and scientifically proven properties,” said Tammo Boinowitz, Senior Vice President and General Manager at Evonik’s Care Solutions Business Line.
No financial details of the deal were disclosed.
Shares in Evonik were up 1.5% at EUR15.78 each on Thursday in Frankfurt.
By Ife Taiwo
Source: Alliance News via Morning Star
Johnson Matthey is expanding its fuel cell operations into China with a £7.5-million facility to manufacture critical components for customers in the region.
Having invested around EUR 25 million in the construction of this 80,000-m3 facility, Borealis can now source and store naphtha for its Porvoo operations from the global market in a more flexible, cost-efficient, and secure way.
Mitsubishi Chemical Holdings, Japan’s largest chemical maker, has named Jean-Marc Gilson, CEO of plant-ingredients maker Roquette Frères (Lestrem, France), as its next CEO, effective 1 April 2021.
